Antiphospholipid Antibodies in Patients with Myasthenia Gravis

Autor:	Kinoshita, Ikuo, Motomura, Masakatsu, Nagasato, Kunihiko, Ichinose, Katsuhiro, Ohishi, Kiyosumi, Takeo, Gou, Satoh, Akira, Nakamura, Tatsufumi, Yoshimura, Toshiro, Tsujihata, Mitsuhiro, Nagataki, Shigenobu
Jazyk:	angličtina
Rok vydání:	1994
Předmět:	Antiphospholipid antibody surgical procedures operative immune system diseases Lupus anticoagulant Antisingle stranded DNA antibody Anticardiolipin antibody musculoskeletal system Myasthenia gravis humanities nervous system diseases
Zdroj:	Acta medica Nagasakiensia. 39(1-3):41-44
ISSN:	0001-6055
Popis:	We measured antiphospholipid antibodies in sera from 94 patients with myasthenia gravis (MG). We found lgG aCL in 14/94 (14.9 % ) lgM aCL in 6/94 (6.4 %) and LA in 4/56 (7.1 %) patients with MG. As a whole 21 of 94 (22.3 % ) patients with MG had some aPL. There was no correlation between the presence of aPL and the severity of MG the presence of hyperplasia of thymus titer of the antiacetylcholine receptor antibodies or anti-single stranded DNA antibodies. Though the percentage of malignant thymoma with aPL were higher than that of malignant thymoma without aPL we thought that aPL were not the specific antibody in malignant thymoma. In MG aPL did not play as the aCL syndrome and seemed to be non-specific antibodies. Acta medica Nagasakiensia. 1994, 39(1-3), p.41-44
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::667ba3767149a99c63ae8c1e5722f51e http://hdl.handle.net/10069/15970 Zobrazit plný text záznamu